Blockade of the CCR3 receptor reduces neutrophil recruitment to the lung during acute inflammation
Open Access
- 19 September 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 116 (5) , 1198-1207
Abstract
Neutrophils represent one of the host's first lines of defense against invading pathogens. However, an aberrant activation can cause damage to the host. In the case of respiratory infections with viral or bacterial pathogens, one of the most common complications is the development of acute respiratory distress syndrome (ARDS), in which neutrophil infiltration into the lung is a hallmark. Neutrophils gain expression of chemokine receptors under inflammatory conditions, and their activation can amplify the neutrophil responses. Earlier studies showed that neutrophils recruited to the lung mucosa during bacterial infection upregulate expression of CCR3 and ex vivo stimulation of CCR3 results in an increased neutrophil activation. Therefore, the modulation of effector functions or migration of neutrophils to target sites through chemokine receptors constitutes an opportunity for pharmacological intervention. We aimed to determine whether the blockade of the CCR3 using the specific antagonist SB-328437 reduces neutrophil recruitment and inflammation in the lung in the LPS-induced lung injury model and influenza infection in mice. We found that neutrophils acquire CCR3 expression in the lung alveolar space. The intraperitoneal administration of SB-328437 reduced neutrophil recruitment to the lung alveolar space and reduced tissue damage in both the LPS-induced lung injury model and influenza infection. Moreover, treatment with SB-328437 reduced the percentage of neutrophils producing TNFα and neutrophil activation in the alveolar space. Together, these data suggest that CCR3 blockade might be a pharmacological strategy to prevent the aberrant neutrophil activation that results detrimental for the host but preserves sufficient effector response to control the pathogen.Keywords
Funding Information
- Conahcyt (CBF2023-2024-1378)
- UNAM-DGAPA-PAPIIT (IA208222)
- initiative Innova-UNAM and Alianza UCMX of the University of California
- COMECYT (EDOMEX-FICDTEM-2021-054, EDOMEX-FICDTEM-2023-128, IN215424, IN212122)
This publication has 29 references indexed in Scilit:
- Locally organised and activated Fth1hi neutrophils aggravate inflammation of acute lung injury in an IL-10-dependent mannerNature Communications, 2022
- Upregulated expression of CCR3 in osteoarthritis and CCR3 mediated activation of fibroblast-like synoviocytesCytokine, 2016
- Pathogenesis of influenza-induced acute respiratory distress syndromeThe Lancet Infectious Diseases, 2014
- Chemokine CCR3 ligands-binding peptides derived from a random phage-epitope libraryImmunology Letters, 2013
- Pulmonary epithelial CCR3 promotes LPS‐induced lung inflammation by mediating release of IL‐8Journal of Cellular Physiology, 2010
- Selective suppression of Th2-mediated airway eosinophil infiltration by low-molecular weight CCR3 antagonistsInternational Immunology, 2007
- Identification of Potent, Selective Non-peptide CC Chemokine Receptor-3 Antagonist That Inhibits Eotaxin-, Eotaxin-2-, and Monocyte Chemotactic Protein-4-induced Eosinophil MigrationJournal of Biological Chemistry, 2000
- Chemokines induce eosinophil degranulation through CCR-3Journal of Allergy and Clinical Immunology, 2000
- Expression of the adhesion molecule CD11b and polymerization of actin by polymorphonuclear granulocytes of patients endangered by sepsisBurns, 1995
- Elevated concentrations of leukotriene D4 in pulmonary edema fluid of patients with the adult respiratory distress syndromeJournal of Clinical Immunology, 1984